Citations are updated once a week. Recently added citations may not appear.
The suggestion is based on each study and bacteria having different weight based on a multitude of factors. For example, how severe a shift is seen.
| Context | Citation |
|---|---|
| Decreases Staphylococcus aureus subsp. aureus 6850 - : vancomycin (antibiotic)[CFS] |
👶
The bactericidal effect of vancomycin is not altered by tranexamic acid, adrenalin, dexamethasone, or lidocaine in vitro. Scientific reports (Sci Rep ) Vol: 11 Issue 1 Pages: 10739 Pub: 2021 May 24 Epub: 2021 May 24 Authors Schwerdt C , Röhner E , Böhle S , Jacob B , Matziolis G , Html Article Publication |
| Decreases Staphylococcus aureus subsp. aureus 6850 - : vancomycin (antibiotic)[CFS] |
👶
Unveiling the Mechanism of Action of 7a-acetoxy-6ß-hydroxyroyleanone on an MRSA/VISA Strain: Membrane and Cell Wall Interactions. Biomolecules (Biomolecules ) Vol: 10 Issue 7 Pages: Pub: 2020 Jun 30 Epub: 2020 Jun 30 Authors Pereira F , Figueiredo T , de Almeida RFM , Antunes CAC , Garcia C , Reis CP , Ascensão L , Sobral RG , Rijo P , Html Article Publication |
| Decreases Staphylococcus aureus subsp. aureus 6850 - : vancomycin (antibiotic)[CFS] |
👶
Vancomycin flushing syndrome in orthopaedic practice: A case report. World journal of orthopedics (World J Orthop ) Vol: 14 Issue 10 Pages: 771-775 Pub: 2023 Oct 18 Epub: 2023 Oct 18 Authors Al-Anii FM , Sadat-Ali M , Al-Tabash KW , AlMulhim AI , AlMousa SA , AlHawas AM , Html Article Publication |
| Decreases Staphylococcus aureus subsp. aureus 6850 - : vancomycin (antibiotic)[CFS] |
👶
Effects of caspofungin, tolcapone and other FDA-approved medications on MRSA susceptibility to vancomycin. Journal of global antimicrobial resistance (J Glob Antimicrob Resist ) Vol: 22 Issue Pages: 283-289 Pub: 2020 Sep Epub: 2020 Apr 1 Authors Moore JA , Meakin M , Earl MH , Kummer TM , McAleer JP , Long TE , Publication |
| Decreases Staphylococcus aureus subsp. aureus 6850 - : vancomycin (antibiotic)[CFS] |
👶
Co-encapsulation of multi-lipids and polymers enhances the performance of vancomycin in lipid-polymer hybrid nanoparticles: In vitro and in silico studies. Materials science & engineering. C, Materials for biological applications (Mater Sci Eng C Mater Biol Appl ) Vol: 61 Issue Pages: 616-30 Pub: 2016 Apr 1 Epub: 2015 Dec 29 Authors Seedat N , Kalhapure RS , Mocktar C , Vepuri S , Jadhav M , Soliman M , Govender T , Publication |
| 0 😁 | 😢 0 |
Explanations /Info /Descriptions are influenced by Large Language Models and may not be accurate and include some hallucinations.Please report any to us for correction.
Copyright 2016 - 2025 Lassesen Consulting, LLC[2007], DBA, Microbiome Prescription All rights served. Permission to data scrap or reverse engineer is explicitly denied to all users.U.S.Code Title 18 PART I CHAPTER 47 § 1030, CETS No.185, CFAA Use of data on this site is prohibited except under written license.There is no charge for individual personal use.Use for any commercial applications or research requires a written license. Caveat emptor: Analysis and suggestions are based on modelling(and thus infererence ) based on studies.The data sources are usually given for those that wish to consider alternative inferences.theories and models. Inventions /Methodologies on this site are Patent Pending.
Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions,
or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not in strict compliance with Personal Health Information Laws. [216.73.216 ]
